Ogeda discovers, develops and commercializes small-molecule drugs for the treatment of endocrine, inflammatory and women's health disorders.
Business Model:
Revenue: $15M
Employees: 11-50
Ogeda was acquired by
Astellas Pharma.
The acquisition happend on 2017-04-02.
Details of the transaction were not public
Address: 47 Rue Adrienne Bolland
City: Gosselies
State: walloon brabant
Zip: 6041
Country: BE
Ogeda discovers, develops and commercializes small-molecule drugs for the treatment of endocrine, inflammatory and women's health disorders.
Contact Phone:
+13271348500
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2015 | Series B | $17.9M | 10/2016 | Series B | $19.8M | 12/2012 | Unattributed | $15.7M | 10/2015 | Series B | 5 | $17.9M |
BNP Paribas Fortis Capricorn Partners Pierre Drion S.R.I.W. Vesalius Biocapital Partners BNP Paribas Fortis Capricorn Partners Pierre Drion S.R.I.W. Vesalius Biocapital Partners |
11/2012 | Private Equity Round | 2 | $13M |
S.R.I.W. Vesalius Biocapital Partners S.R.I.W. Vesalius Biocapital Partners |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|